




LAAD Plus combines IQVIA's LAAD open claims database with PharMetrics® Plus closed claims database to create a comprehensive view of patient and provider actions. Watch the video!
IQVIA delivers unmatched scale and precision by integrating open and closed claims data—empowering life sciences teams with deeper visibility into patient journeys, provider networks, and treatment dynamics.
* Data accumulated from 2013 through the current reporting period.
Enrollees*
De-identified patients*
Lifecycle claims*
Healthcare providers (HCPs)*
Healthcare organizations (HCOs)*
Remittance claims*
When a pharma company needed to find rare disease patients, they hit a wall. Traditional claims data only showed fragments of patient stories. IQVIA's LAAD Plus changed everything by merging open and closed claims for 400+ million patients. The result? They discovered 15% more patients and providers than anyone knew existed, transforming their launch strategy in just weeks. The solution brought together LAAD's massive 300+ million patient database with PharMetrics Plus's 318-million-member records, finally filling in the missing pieces.
When a pharma company needed to find rare disease patients, they hit a wall. Traditional claims data only showed fragments of patient stories. IQVIA's LAAD Plus changed everything by merging open and closed claims for 400+ million patients. The result? They discovered 15% more patients and providers than anyone knew existed, transforming their launch strategy in just weeks. The solution brought together LAAD's massive 300+ million patient database with PharMetrics Plus's 318-million-member records, finally filling in the missing pieces.
What they found surprised everyone. There were 15% more specialists treating these rare disease patients than their original data suggested, hidden at facilities that weren't showing up before. They spotted 10% more diagnoses and 20% more procedures, suddenly seeing the full story of how patients moved through the healthcare system. Perhaps most importantly, they could finally see cash payments that had been invisible, revealing how families were paying for treatments when insurance fell short. Armed with this complete picture, the team could pinpoint exactly which doctors to approach, understand the real challenges patients faced, and build payment programs that worked. They'd found their needles in the haystack.